[1]
“Secondary Efficacy Outcomes from a Phase 2b, Randomized Dose-Finding Study of Tapinarof Cream for the Treatment of Plaque Psoriasis”, J of Skin, vol. 3, p. S16, Nov. 2019, doi: 10.25251/skin.3.supp.16.